May 11, 2020 / 10:46 PM / 14 days ago

BRIEF-TG Therapeutics Reports Qtrly Loss Per Share $0.48

May 11 (Reuters) - TG Therapeutics Inc:

* TG THERAPEUTICS PROVIDES BUSINESS UPDATE AND REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS

* TG THERAPEUTICS INC QTRLY LOSS PER SHARE $0.48

* TG THERAPEUTICS INC - CASH, CASH EQUIVALENTS AND INVESTMENT SECURITIES WERE $78.3 MILLION AS OF MARCH 31, 2020

* TG THERAPEUTICS - BELIEVES CASH, CASH EQUIVALENTS & INVESTMENT SECURITIES ON HAND AS OF MARCH 31 IS SUFFICIENT TO FUND PLANNED OPERATIONS THROUGH 2021-END Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below